Metropolitan Life Insurance Company (MetLife)’s BioLife Solutions BLFS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,954	Closed	-$36.2K	–	301
2024 Q1	$36.2K	Hold	1,954	–	–	﹤0.01%	1567
2023 Q4	$31.8K	Hold	1,954	–	–	﹤0.01%	1681
2023 Q3	$27K	Buy	1,954 +186	+11%	+$2.93K	﹤0.01%	1742
2023 Q2	$39.1K	Hold	1,768	–	–	﹤0.01%	1575
2023 Q1	$38.5K	Sell	1,768 -289	-14%	-$6.5K	﹤0.01%	1532
2022 Q4	$37.4K	Hold	2,057	–	–	﹤0.01%	1644
2022 Q3	$46.8K	Hold	2,057	–	–	﹤0.01%	1504
2022 Q2	$28.4K	Buy	2,057 +1,313	+176%	+$19.3K	﹤0.01%	1852
2022 Q1	$16.9K	Sell	744 -2,209	-75%	-$58.2K	﹤0.01%	2167
2021 Q4	$110K	Sell	2,953 -4,013	-58%	-$172K	﹤0.01%	2424
2021 Q3	$295K	Hold	6,966	–	–	﹤0.01%	1780
2021 Q2	$310K	Buy	6,966 +2,503	+56%	+$88.2K	﹤0.01%	1838
2021 Q1	$161K	Hold	4,463	–	–	﹤0.01%	2165
2020 Q4	$178K	Hold	4,463	–	–	﹤0.01%	2010
2020 Q3	$129K	Buy	+4,463	New	+$96.4K	﹤0.01%	2073

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BLFS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of BioLife Solutions (BLFS) in Q2 2024, closing a stake of 1,954 shares — an estimated $36.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BLFS in Q3 2020 and held it in 15 quarters. The position peaked at $310K in Q2 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining BioLife Solutions position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,954 BioLife Solutions shares in Q2 2024, an estimated $36.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in BioLife Solutions in Q3 2020 and held it in 15 quarters.
Metropolitan Life Insurance Company (MetLife)'s BioLife Solutions position peaked at $310K in Q2 2021.
164 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.